{"schema_version":"secwatch.filing_event.v1","accession":"0001728117-22-000018","form_type":"8-K","ticker":"GOSS","cik":"0001728117","company_name":"Gossamer Bio, Inc.","filed_at":"2022-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.960269+00:00","generated_at":"2026-06-27T02:03:56.694642+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Gossamer Bio reports FY2021 net loss of $234M; cash $325M; pipeline milestones set for 2022","bullets":["Net loss for Q4 2021 was $56.3M ($0.74/share); FY2021 net loss $234M ($3.13/share).","Cash, cash equivalents and marketable securities totaled $325.2M at year-end 2021; expected to fund into H2 2023.","GB004 Phase 2 SHIFT-UC topline data (mild-to-moderate UC) expected Q2 2022; treat-through week 36 data in Q4 2022.","Seralutinib (GB002) Phase 2 TORREY PAH study topline data expected H2 2022, subject to COVID-19 developments.","GB5121 IND active; global Phase 1b/2 trial for primary CNS lymphoma expected to initiate in H1 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001728117-22-000018","json":"https://secwatch.observer/filing/0001728117-22-000018.json","markdown":"https://secwatch.observer/filing/0001728117-22-000018.md","text":"https://secwatch.observer/filing/0001728117-22-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728117/000172811722000018/0001728117-22-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728117/000172811722000018/goss-20220303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T02:03:56.694642+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}